These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9890259)

  • 1. Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice.
    Belzung C; Dubreuil D
    Behav Pharmacol; 1998 Dec; 9(8):691-8. PubMed ID: 9890259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice.
    Belzung C; Agmo A
    Eur J Pharmacol; 1997 Apr; 323(2-3):133-6. PubMed ID: 9128831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice.
    Silva RH; Frussa-Filho R
    Life Sci; 2002 Dec; 72(6):721-30. PubMed ID: 12467912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine.
    Silva RH; Frussa-Filho R
    J Neurosci Methods; 2000 Oct; 102(2):117-25. PubMed ID: 11040408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-CCT, a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice.
    Belzung C; Le Guisquet AM; Griebel G
    Behav Pharmacol; 2000 Apr; 11(2):125-31. PubMed ID: 10877117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide.
    Agmo A; Belzung C
    Neuropharmacology; 1998; 37(2):223-32. PubMed ID: 9680247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
    Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments.
    Frussa-Filho R; Barbosa-Júnior H; Silva RH; Da Cunha C; Mello CF
    Psychopharmacology (Berl); 1999 Nov; 147(2):168-73. PubMed ID: 10591884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.
    Rodgers RJ; Augar R; Berryman N; Hansom CJ; O'Mahony ML; Palmer RM; Stevens A; Tallett AJ
    Psychopharmacology (Berl); 2006 Aug; 187(3):345-55. PubMed ID: 16802164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.
    Calzavara MB; Patti CL; Lopez GB; Abílio VC; Silva RH; Frussa-Filho R
    Life Sci; 2005 Mar; 76(19):2235-46. PubMed ID: 15733938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effects of meprobamate. Interactions with an opiate antagonist in Swiss and BALB/c mice.
    Belzung C; Le Guisquet AM; Agmo A
    Pharmacol Biochem Behav; 2000 Mar; 65(3):465-74. PubMed ID: 10683487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task.
    Ennaceur A; Michalikova S; van Rensburg R; Chazot PL
    Behav Brain Res; 2008 Mar; 188(1):136-53. PubMed ID: 18055029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlordiazepoxide specifically impairs nonspatial reference memory in the cued radial arm maze in rats.
    Olaman SJ; McNaughton N
    Pharmacol Biochem Behav; 2001 Sep; 70(1):133-9. PubMed ID: 11566150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).
    Vignes M; Maurice T; Lanté F; Nedjar M; Thethi K; Guiramand J; Récasens M
    Brain Res; 2006 Sep; 1110(1):102-15. PubMed ID: 16859659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the rat.
    Belzung C; Barreau S; Agmo A
    Eur J Pharmacol; 2000 Apr; 394(2-3):289-94. PubMed ID: 10771294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice.
    Belzung C; Le Guisquet AM; Crestani F
    Psychopharmacology (Berl); 2000 Jan; 148(1):24-32. PubMed ID: 10663414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
    Ferris P; Seward E; Dawson GR
    J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest.
    Roy V; Chapillon P; Jeljeli M; Caston J; Belzung C
    Psychopharmacology (Berl); 2009 Mar; 203(1):131-41. PubMed ID: 18998112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.